Your browser doesn't support javascript.
loading
Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men.
Nakagawa, Ryunosuke; Iwamoto, Hiroaki; Makino, Tomoyuki; Naito, Renato; Kadomoto, Suguru; Akatani, Norihito; Yaegashi, Hiroshi; Kawaguchi, Shohei; Nohara, Takahiro; Shigehara, Kazuyoshi; Izumi, Kouji; Kadono, Yoshifumi; Takamatsu, Atsushi; Yoshida, Kotaro; Mizokami, Atsushi.
Afiliação
  • Nakagawa R; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Iwamoto H; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Makino T; Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa 920-8530, Japan.
  • Naito R; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Kadomoto S; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Akatani N; Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.
  • Yaegashi H; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Kawaguchi S; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Nohara T; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Shigehara K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Izumi K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Kadono Y; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Takamatsu A; Department of Radiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-0934, Japan.
  • Yoshida K; Department of Radiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-0934, Japan.
  • Mizokami A; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
Cancers (Basel) ; 14(19)2022 Oct 02.
Article em En | MEDLINE | ID: mdl-36230745
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article